1.Peripheral Blood Stem Cell Harvest by Transient Radial Arterial Catheterization in Pediatric Patients.
Kye Hyoung LEE ; Moon Kyu KIM ; Chang Ho HONG
Korean Journal of Pediatric Hematology-Oncology 1997;4(1):126-132
BACKGROUND: Peripheral blood stem cell transplantation in children has some difficulties compared with adult cases. Despite the children's total blood volume is small, they have a relatively higher volume of blood per weight than adults. Also, it is hard for the children to maintain 2 central vein during leukapheresis to shorten the time consumed. We compared the artery-harvest and central vein-harvested group for possible risk and stem cell yield in pediatric patients with malignancies. METHODS: From August, 1995 to January, 1997, 21 leukapheresis was performed by 7 patients. The patients who could have 2 central veins for leukapheresis were included in vein-harvested group and the patients who could have only 1 central vein were included in artery-harvested group. The peripheral vein was not used for leukapheresis. COBE Spectra(COBEBCT, Lakewood, CO) was used and priming was done by packed RBCs in patients weighing less than 20kg. Stem cell yield was assessed by MNC, CD34+, CFU-GM, respectively. During leukapheresis, the patients were closely monitored for change in vital sign, evidence for thrombosis, bleeding, hypocalcemia, etc. RESULTS: There was no serious complication in each group of patients. After the leukapheresis, WBC and platelet count decreased but Hb level was increased due to reinfusion of primed packed RBCs. Average flow rate was higher in vein-harvested group but there was no difference in time consumed and results in stem cell assay. CONCLUSION: Peripheral stem cell harvest in children by radial artery can be performed safely and easily without an increased risk or complication. In younger children, it is possible to achieve even more higher stem cell yield. If the patient is unable to maintain 2 central vein for leukapheresis, transient radial arterial catheterization is a safe and convenient method.
Adult
;
Blood Volume
;
Catheterization*
;
Catheters*
;
Child
;
Colony-Forming Units Assay
;
Granulocyte-Macrophage Progenitor Cells
;
Hemorrhage
;
Humans
;
Hypocalcemia
;
Leukapheresis
;
Peripheral Blood Stem Cell Transplantation
;
Platelet Count
;
Radial Artery
;
Stem Cells*
;
Thrombosis
;
Veins
;
Vital Signs
2.A case of seizure associated eHuEPO therapy for hemosiderosis on a chronic renal failure patient.
Kee Hyoung LEE ; Moon Jae KIM ; Chang Whan BAE
Korean Journal of Nephrology 1992;11(2):180-186
No abstract available.
Hemosiderosis*
;
Humans
;
Kidney Failure, Chronic*
;
Seizures*
3.A Case of Allergic Contact Dermatitis to 'Aroma Oils' in an Aroma Therapist.
Hyoung Hun KIM ; Sung Eun CHANG ; Kee Chan MOON
Annals of Dermatology 2003;15(4):169-171
Allergic contact dermatitis from aroma oils has long been recognized and with increasing frequency. Contact dermatitis of the allergic type of fragrances used for aromatherapy has been reported rarely, and only in patients exposed due to their occupation. We report herein a case of allergic contact dermatitis to aroma oils in an aroma therapist. A 25-year-old woman, an aroma therapist, had been treated with topical steroids under the impression of contact dermatitis. She had had pruritic erythematous maculopapules on the arms extending to the hands for the previous 6 months. Patch tests showed strong reactions to aroma oils(3% fennel and 3% juniper). The skin lesions were cleared after she stopped her job. However, re-exposure to aroma oils caused eczematous lesions repeatedly at the sites previously involved. We predict that increasing popularity of aromatherapy will lead to increasing number of patients developing allergic contact dermatitis from aroma oils. This has to be taken into consideration when testing patients with suspected contact dermatitis.
Adult
;
Arm
;
Aromatherapy
;
Dermatitis, Allergic Contact*
;
Dermatitis, Contact
;
Female
;
Foeniculum
;
Hand
;
Humans
;
Oils
;
Patch Tests
;
Skin
;
Steroids
4.Antihypertensive Effects and Safety of Lisinopril in Essential Hypertension.
Yeong Kee SHIN ; Tak Jong HONG ; Chang Hyoung MOON ; Seoung Yoon HWANG ; Bu Woung KIM
Korean Circulation Journal 1994;24(2):313-318
BACKGROUND: Antihypertensive effect and safety of the newer, long acting, nonsulfhydryl angiotensin converting enzyme inhibitor, lisinopril, were studied. METHODS: Twenty eight patients of mild to moderate essential hypertension were administered 10-20mg of lisinopril once daily for ten weeks. Patients were evaluated every two weeks concerning the changes of blood pressure and pulse rate in the sitting position and also any untoward sumptoms and signs attributable to the side effect. Chest X-rey, ECG and laboratory examination were performed in principle two times before and after the completion of medication. RESULTS: The blood pressure declined from 165.4/107.6mmHg to 141.3/92.4mmHg at the end of ten weeks of medication, thus the reduction of 24.1mmHg of systolic pressure and 15.2mmHg of diastolic pressure were observed and the overall effective rate was 85.7%. The pulse rate and laboratory findings were not sigificantly changed before and after the administration of lisinopril. The side effects were observed in 2 cases(7.1%) of mild dry cough and in 2 cases(7.1%) of transitory mild headache and in 1 case(3.6%) of dizziness but no one discontinued medication due to adverse effects. CONCLUSION: Lisinopril proved effective and safe in the treatment of mild to moderate essential hypertension.
Blood Pressure
;
Cough
;
Dizziness
;
Electrocardiography
;
Headache
;
Heart Rate
;
Humans
;
Hypertension*
;
Lisinopril*
;
Peptidyl-Dipeptidase A
;
Thorax
5.Staged Reconstruction for Old Electrical Burns Around the Wrist.
Hyoung Min KIM ; Moon Gu CHOI ; Kee Haeng LEE ; Chang Hoon JUNG ; Hyun Jun SONG
The Journal of the Korean Orthopaedic Association 1997;32(2):434-440
In our series with old electrical burn around the the wrist, there are several characteristics: for example, bad scarring in palm and volar aspect of wrist and distal forearm, large multiple defects of the flexor tendons, low median and ulnar nerve palsy, and occasionally insufficient blood supply. Between 1992 and 1995, we treated 8 cases of 7 patients with staged reconstruction. 4 patients with bilateral involvements had below-elbow amputee of contralateral upper extremity. The common approachs in each were soft tissue coverage, staged tendon reconstructiuon, and opponensplasty. The length of time between the injury and tendon reconstruction was 9 months on an average. Soft tissue coverage consisted of: 1. free tissue transfer (n=3), 2. abdominal (n=3) or groin (n=2). Total numbers of flexor tendon reconstruction were 26. Among them, staged reconstruction using silicone prosthesis were done in 18 tendons and primary tendon graft following tenolysis were done in 8 tendons. The time between first and second stage tendon reconstruction was 4.13 months. In all cases, opponen-splasty using extensor indicis proprius (n=4), extensor pollicis longus (n=2), and extensor digiti mini- mi (n=l), were performed. Good functional improvement of the hand were obtained in all cases. Patient s satisfaction were much better than the degree of functional improvement of the hand.
Amputees
;
Burns*
;
Cicatrix
;
Forearm
;
Groin
;
Hand
;
Humans
;
Prostheses and Implants
;
Silicones
;
Tendons
;
Transplants
;
Ulnar Neuropathies
;
Upper Extremity
;
Wrist*
6.A Clinical Study of Amosulalol Hydrochloride(YM-09538) on the Antihypertensive Effects in Essential Hypertension.
Dong Il LEE ; Chang Hyoung MOON ; Seong Yoon HWANG ; Bu Woung KIM ; Joong Gil LEE ; Yeong Kee SHIN
Korean Circulation Journal 1994;24(1):164-169
BACKGROUND: Newly developed alpha-, beta-receptor blocker, Amosulalol HCI(YM-09538) was evaluated for its hypotensive efficacy, safety and usefulness in patients with mild to moderate essential hypertension. METHODS: Thirty patients of essential hypertension(male 8, female 22), mean age 55 years were included for the study. Amosulalol HCI was administered 20-60mg daily for 10 weeks and initial starting dose was 10mg twice daily and dose was increased 40mg and 60mg daily in cases of insatisfactory hypotensive effect ever 2 weeks interval. Patients were evaluated every two weeks on blood pressure, pulse rate, improvement of subjective symptoms and side effects. Laboratory examinations were carried out routinely in principle two times before trial and after completion of study. RESULTS: Blood pressure began to fall significantly after tow weeks of administration and changed from initial 172.4mmHg of systolic pressure to final 149.3mmHg and from 104.7mmHg of diastolic pressure to final 92.5mmHg. The response rates were marked fall in 30%, satisfactory fall in 40%, thus overall hypotensive effect was observed in 70%. Pulse rate decreased slightiy but significantly from 4 weeks of administration. Improvement of subjective symptoms were observed in 7 cases out of 12 cases and no significant side effects were observedd except of two mild transitory cases of polyuria and indigestion. Laboratory examination also did not show any significant changes before and after medication. CONCLUSION: The daily administration fo 20-60mg of Amosulalol HCI to moderate essectial hypertension seems to be effective and safe with clinical usefulness.
Blood Pressure
;
Dyspepsia
;
Female
;
Heart Rate
;
Humans
;
Hypertension*
;
Nifedipine
;
Perindopril
;
Polyuria
7.A Case of Endometriosis in the Abdominal Subcutaneous Tissue.
Hyun Ju MOON ; Tae Gyu AHN ; Kyung LEE ; Hyoung Gyun ROH ; Sang Joon CHOI ; Chang Hoon SONG ; Hyuk JUNG
Korean Journal of Obstetrics and Gynecology 1999;42(3):641-645
the ineidence of abdominal subcutaneous endometriosis is quite rare we have experienced one case of subcutaneous endometriosis. The typical clinical bistory and local findings of endometriasis enabk us to make the conect diagnosis. the treatment of choice is complete surgical excision of endometrial tissue and post operative medical therapy. This case was reported with a brief review of the comcemed literatures.
Diagnosis
;
Endometriosis*
;
Female
;
Subcutaneous Tissue*
8.Experience of Redo Urethroplasty for Complicated Recurrent Hypospadias.
Hyoung Chang LEE ; Hong Sang MOON ; Ki Yong SHIN ; Young Nam WOO
Korean Journal of Urology 1999;40(10):1367-1370
PURPOSE: Patients requiring urethral reconstruction due to failed hypospadias repairs present a considerable technical challenge. Herein we report the experience of redo urethroplasties for complicated recurrent hypospadias. MATERIALS AND METHODS: From 1987 to 1997, we performed redo urethroplasty in 11 cases with complicated recurrent hypospadias. Types of recurrent hypospadias were coronal (1 case), distal shaft (4 cases), mid-shaft (1 case), and penoscrotal (5 cases) hypospadias. The interval between the last operation and redo operation was distributed from 8 months to 5 years. We analysed preoperative status, operative methods and their complications retrospectively. RESULTS: We performed urethroplasties using scrotal skin flap or buccal mucosal graft in only 2 cases. In spite of a paucity of usable penile skin, we performed urethroplasties with maximal use of remaining penile skin. Mathieu method was used in one case with coronal type. Mustarde operation was used in 4 cases with distal shaft hypospadias. And in 5 cases with penoscrotal type, we used Thiersch-Duplay method. Six of 11 patients had complications such as urethrocutaneous fistulas (4 cases) or recurrent hypospadias (2 cases) which were managed successfully later. CONCLUSIONS: Urethroplasty using penile skin maximally such as Mathieu, Mustarde, or Thiersch-Duplay methods appears to achieve success in patient with recurrent hypospadias subsequent to previous failed repairs.
Female
;
Fistula
;
Humans
;
Hypospadias*
;
Male
;
Mustard Plant
;
Retrospective Studies
;
Skin
;
Transplants
9.Treatment of Avascular Necrosis of the Femoral Head with Free Vascularized Fibular Graft.
Kee Haeng LEE ; Youn Soo KIM ; Moon Gu CHOI ; Chang Hoon JEONG ; Hyoung Min KIM ; Il Jae IHM
The Journal of the Korean Orthopaedic Association 1998;33(4):941-951
We reviewed 46 hips of the 36 patients treated with free vascularized fibular graft for avascular necrosis of femoral head with a mean follow-up of 39.9 months (ranging from 2 years to 6 years 4 months). There were thirty-four men and two women. The mean age of patients at the time of operation was 36.6 years (ranging from seventeen to fifty-seven years). The procedure was performed on both hips in ten patients. Of the 46 hips, twenty-nine were idiopathic, ten alcoholic, six steroid induced, and one traumatic. According to Ficats stage, there were eighteen in Stage 2A, fifteen in Stage 2B and thirteen in Stage 3. According to Ohzonos classification, there were four in Type 1B, forty in Type 1C and one in Type 3B. Clinical assessments according to the cause and severity of the disease were evaluated using Harris hip scoring system. Thirty-two hips(69.6%) were excellent, 9 hips(19.6%) were good, 2 hips(4.3%) were fair, and 3 hips(6.5%) were poor. Therefore clinically satisfactory results, including excellent and good, were obtained in 41 hips(89.2%). Radiographic assessments according to healing of avascular necrosis lesion and collapsing the femoral head postoperatively were performed. Thirty hips(65.2%) were excellent, 9 hips(19.6%) were good, 4 hips(8.7%) were fair, and 3 hips(6.5%) were poor. Therefore radiographic satisfactory results were obtained in 39 hips(84.8%). Clinical and radiographic assessments according to Ohzonos classification were also evaluated. Clinically satisfactory result were obtained in 6 hips(100%) of Type 1A and 3B in 33 hips(82.5%) of Type 1C. The etiological factors didn t affect the results. There were two cases of peroneal nerve palsy in which one was irreversible and one case of clawing of great toe as complications. In conclusion, free vascularized fibular graft appears to be a very effective method for Ficats stage 2A, 2B, and early stage 3 of symptomatic avascular necrosis of femoral head, in Ohzonos Type 1C which have a high incidence of collapse.
Alcoholics
;
Animals
;
Classification
;
Female
;
Follow-Up Studies
;
Head*
;
Hip
;
Hoof and Claw
;
Humans
;
Incidence
;
Male
;
Necrosis*
;
Paralysis
;
Peroneal Nerve
;
Toes
;
Transplants*
10.Changes of Tc - 99m - HDP Bone Scan Findings in Avascular Necrosis of the Femoral head ( ANFH ) Treated with Vascularized Fibular Graft.
Hyoung Min KIM ; Kee Haeng LEE ; Moon Gu CHOI ; Chang Hoon JUNG ; Hyung Rae CHO ; Mi Sook SUNG
The Journal of the Korean Orthopaedic Association 1997;32(2):237-242
Vascularized fibular graft is one of the treatment option for avascular necrosis of femoral head (ANFH) and has been known as providing a strut mechanical support and new vascular bed. It is very important to evaluate a healing process in femoral head after vascularization procedure. But a plain radiographic finding has a problem to assess pathological changes of ANFH treated with vascularized fibular graft. Authors analyzed chronogical changes of Tc-99m-HDP bone scan in 31 cases of ANFH treated with vascularized fibular graft from April, 1991 to May, 1994 and following results were obtained. l. Until 2 months after surgery, no change in size of cold defect area and no significant change in extent of RI uptake in reactive zone were noted. 2. During 2 months and 6 months after surgery, slight decrease in size of cold defect area and minimal changes in extent of RI uptake in reactive zone were observed. 3. During 6 months and 12 months after surgery, size of cold defect area decreased to 1/2 and changes in extent and degree of RI uptake in reactive zone were observed. 4. During 1 year and 2 years after surgery, size of cold defect area were minimal and sometimes faded away. RI uptake with decreased density in reactive zone broadened and moved to subchondral area. 5. After 2 years after surgery, cold area faded away and small increased RI uptake were observed in same site. In conclusion, Tc-99m-HDP bone scan which is economic and easily applicable in a patient is very useful for follow up study in ANFH treated with vascularized fibular graft.
Follow-Up Studies
;
Head*
;
Hip
;
Humans
;
Necrosis*
;
Transplants*